Loading clinical trials...
Loading clinical trials...
The Integration Pattern of Non-Animal Stabilized Hyaluronic Acid (NASHA)- and Optimum Balance Technology (OBT)-Based Fillers: An Ultrasound and Magnetic Resonance Imaging (MRI) Study
Conditions
Interventions
Restylane Injectables
Locations
1
Canada
Erevna Innovations Inc.
Westmount, Quebec, Canada
Start Date
December 11, 2025
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
January 22, 2026
NCT07383766
NCT07151859
NCT07202117
NCT07261748
NCT07188818
NCT07370545
Lead Sponsor
Erevna Innovations Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions